Wegovy Semaglutide tablets

Wegovy semaglutide tablets are a prescription medication designed to support weight management in adults. Semaglutide is a GLP-1 receptor agonist — a class of medication that works with your body's natural systems to help regulate appetite and food intake. It is prescribed as part of a comprehensive weight management programme that includes dietary and lifestyle support.

Semaglutide has been extensively studied and is approved by the MHRA for weight management in adults with a BMI of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher with weight-related health conditions. Clinical trials have demonstrated that when combined with diet and physical activity changes, semaglutide can support meaningful and sustained weight reduction over time.

Treatment with Wegovy semaglutide tablets involves a gradual titration schedule. The medication is available in four strengths: 1.5mg, 4mg, 9mg, and 25mg. Your prescriber will start you on a lower dose and increase it gradually over several weeks to allow your body to adjust and to identify the dose that works best for you. This personalised approach helps minimise side effects whilst maximising benefit.

This is a prescription-only medication. Before starting treatment, you will have an online consultation with a UK registered prescriber who will review your medical history, current health, and suitability for semaglutide. Your prescriber will discuss how the medication works, what to expect, and how it fits into your overall weight management plan. Ongoing support is provided throughout your treatment to monitor your progress and make any necessary adjustments.

Choosing Wegovy semaglutide tablets means accessing evidence-based medical support from qualified UK healthcare professionals without the need to attend a physical clinic. Your medication is delivered directly to your home, and you receive guidance on administration and ongoing care.